9997 — Kangji Medical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$7.01bn
- HK$4.48bn
- CNY926.02m
- 87
- 62
- 60
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 391 | 310 | 534 | 563 | 589 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -16.8 | -1.19 | -74.6 | -58.3 | -86.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -55.4 | -96 | -36 | -207 | -116 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 326 | 221 | 436 | 319 | 420 |
Capital Expenditures | -9.56 | -17.8 | -31 | -115 | -87.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 193 | -593 | -129 | -255 | -304 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 183 | -611 | -160 | -370 | -392 |
Financing Cash Flow Items | 0 | -494 | -0.196 | -1.88 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -106 | 2,152 | -97.6 | -473 | -244 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 405 | 1,565 | 143 | -439 | -219 |